Genomic Features for Therapeutic Insights of Chemotherapy-Resistant, Primary Mediastinal Nonseminomatous Germ Cell Tumors and Comparison with Gonadal Counterpart.

MLA

Necchi, Andrea, et al. “Genomic Features for Therapeutic Insights of Chemotherapy-Resistant, Primary Mediastinal Nonseminomatous Germ Cell Tumors and Comparison with Gonadal Counterpart.” The Oncologist, vol. 24, no. 4, Apr. 2019, pp. e142–45. EBSCOhost, https://doi.org/10.1634/theoncologist.2018-0430.

APA

Necchi, A., Bratslavsky, G., Chung, J., Millis, S., Gay, L. M., Ali, S. M., & Ross, J. S. (2019). Genomic Features for Therapeutic Insights of Chemotherapy-Resistant, Primary Mediastinal Nonseminomatous Germ Cell Tumors and Comparison with Gonadal Counterpart. The Oncologist, 24(4), e142–e145. https://doi.org/10.1634/theoncologist.2018-0430

Chicago

Necchi, Andrea, Gennady Bratslavsky, Jon Chung, Sherri Millis, Laurie M Gay, Siraj M Ali, and Jeffrey S Ross. 2019. “Genomic Features for Therapeutic Insights of Chemotherapy-Resistant, Primary Mediastinal Nonseminomatous Germ Cell Tumors and Comparison with Gonadal Counterpart.” The Oncologist 24 (4): e142–45. doi:10.1634/theoncologist.2018-0430.